Table 1.
Descriptive characteristics of 10 523 surgeries involving salpingectomy in the Calgary Laboratory Services database (2014–2016) overall and by STIC status
| Total population (n = 10 523) |
STIC positive (n = 40, 0.4%) |
STIC negative (n = 10 483, 99.6%) |
||||
|---|---|---|---|---|---|---|
| Descriptive characteristics | No. (%) | No. (%) | No. (%) | |||
| Age, mean (SD), y | 45.9 (13.0) | 60.8 (10.7) | 45.9 (13.0) | |||
| <40 | 3963 (37.7) | 1 (2.5) | 3962 (37.8) | |||
| 40–49 | 3112 (29.6) | 5 (12.5) | 3107 (29.6) | |||
| 50–59 | 1771 (16.8) | 16 (40.0) | 1755 (16.7) | |||
| 60+ | 1677 (15.9) | 18 (45.0) | 1659 (15.8) | |||
| Collection year | ||||||
| 2014 | 3316 (31.5) | 11 (27.5) | 3305 (31.5) | |||
| 2015 | 3538 (33.6) | 10 (25.0) | 3528 (33.7) | |||
| 2016 | 3669 (34.9) | 19 (47.5) | 3650 (34.8) | |||
| Surgical indication* | ||||||
| Cancer† | ||||||
| Yes | 6023 (57.2) | 35 (87.5) | 5988 (57.1) | |||
| No | 4500 (42.8) | 5 (12.5) | 4495 (42.9) | |||
| Post-cancer treatment‡ | ||||||
| Yes | 321 (3.1) | 10 (25.0) | 311 (3.0) | |||
| No | 10 202 (96.9) | 30 (75.0) | 10 172 (97.0) | |||
| Risk reducing§ | ||||||
| Yes | 354 (3.4) | 5 (12.5) | 349 (3.3) | |||
| No | 10 169 (96.6) | 35 (87.5) | 10 134 (96.7) | |||
| Benign/nonmalignant‖ | ||||||
| Yes | 7737 (73.5) | 11 (27.5) | 7726 (73.7) | |||
| No | 2786 (26.5) | 29 (72.5) | 2757 (26.3) | |||
Categories are not mutually exclusive; cases could be classified as having more than one reason for surgery. STIC = serous tubal intraepithelial carcinoma.
Cancer includes: cancer-related surgery, cancer rule-out, adenocarcinoma in situ, high-grade squamous intraepithelial lesion, mass, tumor.
Post-cancer treatment: clinical information text field indicated surgery was occurring post-chemotherapy and/or adjuvant therapy.
Risk-reducing includes: risk reducing, prophylactic, BRCA positive, BRCA test pending, family history of cancer (breast/ovarian/uterine), and family history of BRCA positive.
Benign/nonmalignant includes: adenomyosis, bleeding, cesarean section, cyst, dyspareunia, dysplasia, ectopic pregnancy, endometriomas, endometriosis, fibroid, GI tract related, gynecological abnormalities, hyperplasia, incontinence, IUD issue, pain, pelvic adhesion, pelvic inflammatory disease, pregnancy complications, prolapse, torsion, transgender surgery, tubal ligation (sterilization), tubal related, and sepsis.